Tamra E Werbowetski-Ogilvie

10PUBLICATIONS
51CO-AUTHORS
Haematological tumoursMolecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)Gene and molecular therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 18, 2024
A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing.

Olivier Saulnier, Jamie Zagozewski, Lisa Liang

|Sep 19, 2023
Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression.

Stephanie Borlase, Alexandria DeCarlo, Ludivine Coudière-Morrison

|May 02, 2023
Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma.

Emma Martell, Helgi Kuzmychova, Esha Kaul

|Sep 21, 2022
Failure of human rhombic lip differentiation underlies medulloblastoma formation.

Liam D Hendrikse, Parthiv Haldipur, Olivier Saulnier

|Jul 14, 2022
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.

Jamie Zagozewski, Stephanie Borlase, Brent J Guppy

|Mar 13, 2021
From sorting to sequencing in the molecular era: the evolution of the cancer stem cell model in medulloblastoma.

Tamra E Werbowetski-Ogilvie

Pageof 2

Frequent Collaborators

6 joint publications

Olivier Saulnier

6 joint publications

Vijay Ramaswamy

5 joint publications

Christopher J Porter

4 joint publications

Olivier Ayrault